Jain Rita
Insider CIK 1707797 · CCXI EVP, Chief Medical Officer, Director · ANAB Director · AKBA SVP, Chief Medical Officer · AVTX Director · PRVB Director · IMVT Chief Medical Officer · SABS Director · TRAX Director · CLDX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2026-09-30 | 2026-10-02 | 1,322 | $12.29 | $16.2K | 1,322 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2026-06-30 | 2026-07-02 | 1,080 | $15.04 | $16.2K | 1,080 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2026-06-25 | 2026-06-29 | 26,000 | — | $0 | 26,000 | SEC↗ |
| TRAX First Tracks Biotherapeuti | M Exercise deriv | 2026-06-15 | 2026-06-17 | 6,030 | — | $0 | 0 | SEC↗ |
| TRAX First Tracks Biotherapeuti | M Exercise deriv | 2026-06-15 | 2026-06-17 | 1,300 | — | $0 | 0 | SEC↗ |
| TRAX First Tracks Biotherapeuti | M Exercise | 2026-06-15 | 2026-06-17 | 7,330 | — | $0 | 19,194 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2026-06-02 | 2026-06-04 | 20,100 | — | $0 | 20,100 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-05-12 | 2026-05-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-05-12 | 2026-05-14 | 42,000 | — | $0 | 42,000 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-05-12 | 2026-06-12 | 2,500 | — | $0 | 2,500 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-05-12 | 2026-06-12 | 7,000 | — | $0 | 7,000 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 6,030 | — | $0 | 6,030 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 10,600 | — | $0 | 10,600 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 8,015 | — | $0 | 8,015 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 16,510 | — | $0 | 16,510 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 16,510 | — | $0 | 16,510 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 5,500 | — | $0 | 5,500 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 1,300 | — | $0 | 1,300 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 4,000 | — | $0 | 4,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2026-03-31 | 2026-04-01 | 1,339 | $12.13 | $16.2K | 1,339 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-01-06 | 2026-01-08 | 5,500 | — | $0 | 5,500 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-01-06 | 2026-01-08 | 4,000 | — | $0 | 4,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2026-01-05 | 2026-01-07 | 240,000 | — | $0 | 240,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2025-12-31 | 2026-01-05 | 1,043 | $14.74 | $15.4K | 1,043 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2025-09-30 | 2025-10-02 | 1,572 | — | $0 | 1,572 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 40,200 | — | $0 | 40,200 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2025-06-15 | 2025-06-17 | 1,300 | — | $0 | 1,300 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2025-06-15 | 2025-06-17 | 6,030 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2025-06-15 | 2025-06-17 | 7,330 | — | $0 | 11,864 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 16,500 | — | $0 | 16,500 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2025-01-07 | 2025-01-07 | 6,030 | — | $0 | 6,030 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2025-01-07 | 2025-01-07 | 16,510 | — | $0 | 16,510 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2024-06-15 | 2024-06-18 | 3,234 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2024-06-15 | 2024-06-18 | 1,300 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2024-06-15 | 2024-06-18 | 4,534 | — | $0 | 4,534 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2024-01-03 | 2024-01-05 | 6,030 | — | $0 | 6,030 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2024-01-03 | 2024-01-05 | 16,510 | — | $0 | 16,510 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 66,000 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2023-04-03 | 2023-04-06 | 10,600 | — | $0 | 10,600 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2023-04-03 | 2023-04-06 | 8,015 | — | $0 | 8,015 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2023-04-03 | 2023-04-06 | 3,900 | — | $0 | 3,900 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2023-04-03 | 2023-04-06 | 3,234 | — | $0 | 3,234 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2023-02-16 | 2023-02-21 | 17,100 | — | $0 | 17,100 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 66,000 | — | $0 | 66,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 23,948 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 307 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 14,393 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 21,052 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 4,504 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 12,287 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer deriv | 2022-10-20 | 2022-10-24 | 11,600 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | D To issuer | 2022-10-20 | 2022-10-24 | 35,863 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2022-05-20 | 2022-05-24 | 7,726 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2022-05-20 | 2022-05-24 | 7,726 | — | $0 | 35,863 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2022-03-27 | 2022-03-29 | 5,251 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2022-03-27 | 2022-03-29 | 5,251 | — | $0 | 28,137 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2022-02-22 | 2022-02-24 | 11,600 | — | $0 | 11,600 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2022-02-22 | 2022-02-24 | 14,700 | — | $0 | 14,700 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2021-10-05 | 2021-10-07 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2021-05-21 | 2021-05-24 | 4,660 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2021-05-21 | 2021-05-24 | 4,660 | — | $0 | 22,886 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2021-05-20 | 2021-05-24 | 7,726 | — | $0 | 7,726 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2021-05-20 | 2021-05-24 | 4,504 | — | $0 | 4,504 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2021-03-27 | 2021-03-30 | 5,251 | — | $0 | 5,251 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2021-03-27 | 2021-03-30 | 5,251 | — | $0 | 18,226 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2021-03-19 | 2021-03-23 | 342,300 | — | $0 | 342,300 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2021-03-19 | 2021-03-31 | 342,300 | — | $0 | 342,300 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2021-03-19 | 2021-03-23 | 109,365 | — | $0 | 129,365 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2021-03-19 | 2021-03-31 | 97,600 | — | $0 | 117,600 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2021-03-19 | 2021-03-31 | 11,765 | — | $0 | 129,365 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2021-01-22 | 2021-01-25 | 220,000 | — | $0 | 220,000 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2021-01-22 | 2021-01-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2020-05-21 | 2020-05-26 | 4,660 | — | $0 | 4,660 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2020-05-21 | 2020-05-26 | 2,888 | — | $0 | 2,888 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2020-03-27 | 2020-03-31 | 5,251 | — | $0 | 10,502 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2020-03-27 | 2020-03-31 | 5,251 | — | $0 | 12,975 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2019-05-23 | 2019-05-23 | 12,287 | — | $0 | 12,287 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award | 2019-05-23 | 2019-05-23 | 7,724 | — | $0 | 7,724 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | D To issuer | 2019-04-11 | 2019-04-12 | 4,409 | $7.70 | $33.9K | 96,332 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2019-03-27 | 2019-03-29 | 15,753 | — | $0 | 15,753 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2019-02-28 | 2019-03-05 | 115,000 | — | $0 | 115,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2019-02-28 | 2019-03-05 | 80,000 | — | $0 | 100,741 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | F Tax w/h | 2018-12-12 | 2018-12-13 | 8,659 | $8.94 | $77.4K | 20,741 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-02-28 | 2018-03-02 | 41,800 | — | $0 | 41,800 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2018-02-28 | 2018-03-02 | 29,400 | — | $0 | 29,400 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2017-05-31 | 2017-06-02 | 200,000 | — | $0 | 200,000 | SEC↗ |